Effect of some statin group of drugs on the phase profile of liposomal membrane - A fluorescence anisotropy study

Phase Transitions

Volumn 82, Issue 11, 2009, Pages 821-830

  Bhandary, Suman ^a   Basu, Ruma ^b   Das, Sukhen ^a   Nandy, Papiya ^a  

^a JADAVPUR UNIVERSITY   (India)

^b Jogamaya Devi College   (India)

Author keywords

1,6 diphenylhexatriene; Fluorescence anisotropy; Motionally restricted lipid molecules; Phase transition temperature; Statins; Van't Hoff enthalpy

Indexed keywords

DIPHENYLHEXATRIENE; FLUORESCENCE ANISOTROPY; LIPID MOLECULES; PHASE TRANSITION TEMPERATURES; STATINS; VAN'T HOFF ENTHALPY;

ANISOTROPY; ENTHALPY; FLUIDIZATION; FLUORINE CONTAINING POLYMERS; LIPOSOMES; MELTING; MOLECULES; PHOSPHOLIPIDS; SUPERCONDUCTING TRANSITION TEMPERATURE;

FLUORESCENCE;

EID: 71449095630     PISSN: 01411594     EISSN: 10290338     Source Type: Journal    
DOI: 10.1080/01411590903432616     Document Type: Article

References (46)

1. D.D. Lasic, Liposomes: From Physics to Applications, Elsevier, Amsterdam, 1993.
2. J.A. Virtanen, K.H. Cheng, and P. Somerharju, Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model, Proc. Natl. Acad. Sci. 95 (1998), pp. 4964-4969.
3. A.K. Ghosh, J. Mukherjee, R. Basu, M. Bhattacharya, and P. Nandy, A fluorescence anisotropy study of stabilizing effect of tri- and tetra-nitrovasodilatory drugs on DPPC liposomal membrane, Biochim. Biophys. Acta 1153 (1993), pp. 20-22.
4. A.K. Ghosh, R. Basu, and P. Nandy, Lipid perturbation of liposomal membrane of dipalmitoyl phosphatidylcholine by chloroquine sulphate - A fluorescence anisotropic study, Colloids Surf., B: Biointerfaces 4 (1995), pp. 1-4.
5. A.K. Ghosh, N. Pore, R. Basu, S. De, and P. Nandy, Lipid perturbation by corticosteroids: An anisotropic study, Colloids Surf., B: Biointerfaces 7 (1996), pp. 65-68.
6. A.K. Ghosh, R. Basu, S. Dey, S. Das, N.P. Nayak, B. Barat, and P. Nandy, Lipid-disordering effect of aspirin on the liposomal membrane of dipalmitoyl phosphatidyl choline - A fluorescence anisotropy study, Colloids Surf., B: Biointerfaces 4 (1995), pp. 309-311.
7. S.B. Kulkarni, M. Singh, and G.V. Betageri, Encapsulation, stability and in vitro release characteristics of liposomal formulations of colchicines, J. Pharm. Pharmacol. 49 (1997), pp. 491-495.
8. H.P. Singh, P. Utreja, A.K. Tiwary, and S. Jain, Elastic liposomal formulation for sustained delivery of colchicine: In vitro characterization and in vivo evaluation of anti-gout activity, AAPS J. 11 (2009), pp. 54-64.
9. M. Chatterjee, P.K. Das, and P. Nandy, Effect of concanavaline - A on leishmania parasite membrane fluidity: A fluorescence study, J. Surf. Sci. Technol. 15 (1999), pp. 1-5.
10. U. Subuddhi and A.K. Mishra, Effect of sodium deoxycholate and sodium cholate on DPPC vesicles: A fluorescence anisotropy study with diphenylhexatriene, J. Chem. Sci. 119 (2007), pp. 169-174.
11. L. Panicker and K.P. Mishra, Influence of salicylic acid on the biophysical properties of dipalmitoyl phosphatidylcholine vesicles, Phase Transitions 81 (2008), pp. 65-76.
12. T.P. Johnston, L.B. Nguyen, W.A. Chu, and S. Shefer, Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis, Int. J. Pharm. 229 (2001), pp. 75-86.
13. E.A. Stein, M.L. Lane, and P. Laskarzewski, Comparison of statins in hypertriglyceridemia, Amer. J. Cardiol. 81 (1998), pp. 66-69.
14. D.J. Oh and B.C. Lee, Solubility of simvastatin and lovastatin in mixtures of dichloromethane and supercritical carbon dioxide, J. Chem. Eng. Data 52 (2007), pp. 1273-1279.
15. R. Patel, G. Buckton, and S. Gaisford, The use of isothermal titration calorimetry to assess the solubility enhancement of simvastatin by a range of surfactants, Thermochimi. Acta 456 (2007), pp. 106-113.
16. C. Stancu and A. Sima, Statins: Mechanism of action and effects, J. Cell. Mol. Med. 5 (2001), pp. 378-387.
17. R.S. Blumenthal, Statins: Effective antiatherosclerotic therapy, Amer. Heart. J. 139 (2000), pp. 577-583.
18. Y. Kureishi, Z. Luo, I. Shiojima, A. Bialik, D. Fulton, D.J. Lefer, W.C. Sessa, and K. Walsh, The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals, Nat. Med. 6 (2000), pp. 1004-1010.
19. J. Shepherd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, P.W. MacFarlane, J.H. McKillop, and C.J. Packard, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group, N. Engl. J. Med. 333 (1995), pp. 1301-1307.
20. S. Kagami, H. Kanari, A. Suto, M. Fujiwara, K. Ikeda, K. Hirose, N. Watanabe, I. Iwamoto, and H. Nakajima, HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells, Int. Arch. Allergy Immunol. 146 (2008), pp. 61-66.
21. B.P. Leung, N. Sattar, A. Crilly, M. Prach, D.W. McCarey, H. Payne, R. Madhok, C. Campbell, J.A. Gracie, F.Y. Lie, and I.B. McInnes, A novel anti-inflammatory role for simvastatin in inflammatory arthritis, J. Immunol. 170 (2003), pp. 1524-1530.
22. W. Dowhan, Molecular basis for membrane phospholipid diversity: Why are there so many lipidšAnnu. Rev. Biochem. 66 (1997), pp. 199-232.
23. S. Uran, A. Larsen, P.B. Jacobsen, and T. Skotland, Analysis of phospholipid species in human blood using normal-phase liquid chromatography coupled with electrospray ionization ion-trap tandem mass spectrometry, J. Chromatogr. B. 758 (2001), pp. 265-275.
24. S. Leekumjorn and A.K. Sum, Molecular simulation study of structural and dynamic properties of mixed DPPC/DPPE bilayers, Biophys. J. 90 (2006), pp. 3951-3965.
25. Z. Cui and M. Houweling, Phosphatidylcholine and cell death, Biochim. Biophys. Acta. 1585 (2002), pp. 87-96.
26. H. Chakraborty and M. Sarkar, Interaction of piroxicam and meloxicam with DMPG/DMPC mixed vesicles: Anomalous partitioning behavior, Biophys. Chem. 125 (2007), pp. 306-313.
27. T. Imura, H. Sakai, H. Yamauchi, C. Kaise, K. Kozawa, S. Yokoyama, and M. Abe, Preparation of liposomes containing Ceramide 3 and their membrane characteristics, Colloids Surf. B: Biointerfaces 20 (2001), pp. 1-8.
28. V. Bambeke, A. Kerkhofs, A. Schanck, C. Remacle, E. Sonveaux, P.M. Tulkens, and M.P. Mingeot-Leclercq, Biophysical studies and intracellular destabilization of pH-sensitive liposomes, Lipids 35 (2000), pp. 213-223.
29. F. Barbato, G. di Martino, L. Grumetto, and M.I. La Rotonda, Prediction of drug-membrane interactions by IAM-HPLC: Effects of different phospholipid stationary phases on the partition of bases, Eur. J. Pharm. Sci. 22 (2004), pp. 261-269.
30. H.O. Hauser, The effect of ultrasonic irradiation on the chemical structure of egg lecithin, Biochem. Biophys. Res. Commun. 45 (1971), pp. 1049-1055.
31. R.E. Pagano and M. Takeichi, Adhesion of phospholipid vesicles to Chinese hamster fibroblasts, J. Cell Biol. 74 (1977), pp. 531-546.
32. K. Wojtowicz, Comparison of the effect of 4-hydroxycoumarin and umbelliferone on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers, Pharmacol. Rep. 60 (2008), pp. 555-560.
33. L. Panicker, S.L. Narasimhan, and K.P. Mishra, Reduced fluidity of dipalmitoyl phosphatidic acid membranes by salicylic acid, Thermochim. Acta 432 (2005), pp. 41-46.
34. L. Panicker and K.P. Mishra, Nuclear magnetic resonance and thermal studies on the interaction between salicylic acid and model membranes, Biophys. Chem. 120 (2005), pp. 15-23.
35. S. Bhandary, R. Basu, S. Manna, S. Das, and P. Nandy, Role of non-lamellar-forming lipid in promotion of liposomal fusion, Phase Transitions 82 (2009), pp. 221-227.
36. J.R. Lakowicz, Principles of Fluorescence Spectroscopy, 2nd ed., Kluwer Academic/Plenum Publishers, New York, 1999, pp. 353-381.
37. L.A. Marky and K.J. Breslauer, Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves, J. Biopolymers, 26 (1987), pp. 1601-1620.
38. S. De, R. Basu, and P. Nandy, Cholesterol incorporation in liposomal membrane: Change in Van't Hoff enthalpy, J. Indian Chem. Soc. 75 (1998), pp. 405-406.
39. S. De, A.K. Ghosh, R. Basu, and P. Nandy, Calculation of van't Hoff enthalpy associated with aspirin-induced change in liposomal membrane anisotropy, Phys. Med. Biol. 41 (1996), pp. 383-386.
40. D. Houbre, P. Schindler, E. Trifilieff, B. Luu, and G. Duportail, Selectivity of lipid-protein interaction with myelin proteolipids PLP and DM-20. A fluorescence anisotropy study, Biochim. Biophys. Acta 1029 (1990), pp. 136-142.
41. M. Shinitzky and Y. Barenholz, Fluidity parameters of lipid regions determined by fluorescence polarization, Biochim. Biophys. Acta 515 (1978), pp. 367-394.
42. P. Glatz, Limited rotational diffusion of DPH in human erythrocyte membranes, Anal. Biochem. 87 (1978), pp. 187-194.
43. R.D. Kaiser and E. London, Location of diphenylhexatriene (DPH) and its derivatives within membranes: Comparison of different fluorescence quenching analyses of membrane depth, Biochem. 37 (1998), pp. 8180-8190.
44. M. Bhattacharyya and P. Nandy, Effect of nicotinic acid on micorviscisity in mixed liposomal system of lecithin and sphingomyelin, Arch. Biochem. Biophys. 275 (1989), pp. 379-384.
45. D. Skorda and C.G. Kontoyannis, Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy, Talanta 74 (2008), pp. 1066-1070.
46. B.G. Chaudhari, N.M. Patel, P.B. Shah, and K.P. Modi, Development and validation of a HPTLC method for the simultaneous estimation of Atorvastatin calcium and Ezetimibe, Indian J. Pharm. Sci. 68 (2006), pp. 793-796.